Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

OFF-PUMP CORONARY ARTERY BYPASS GRAFT: LIMA-DA

Cipriano Abad

Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

ESC 2024 Insights: Comparison of Different Calcium Modification Stra…

ESC 2024 Insights

K. Yasumura

Balloon Stuck During PCI

Itsik Ben-Dor

Basics of OCT Imaging

FACET

N. Pinilla-Echeverri

High-Risk Cardiac Surgery and Pre-Op Optimization with Impella Base …

St. Louis Shock & Heart Failure Symposium 2022

J. Leidenfrost

OCT Use in Vessel Assessment: Calcium and Beyond

FACET

N. Pinilla-Echeverri

The History of Invasive Cardiac Procedures - Updated

Joel Gorfinkel

Plant-based Diets for Improving Lipids

National Lipid Association

K. Williams

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Enhanced Recovery After Cardiac Surgery and AKI Prevention

The 10th Annual Western New England Acute Cardiology Conference

D. Engelman

Is FFR Dead? Addressing Contrarian FFR Studies

Scottsdale Interventional Forum 2023

M. Kern